After delaying a shareholder vote by one week so it could consider a $1.6 billion acquisition bid from former employees, the genetic analysis firm Affymetrix says an earlier $1.3 billion offer from ...

In the wake of Thermo Fisher Scientific, Inc.'s TMO impending acquisition of Affymetrix, Inc. AFFX, the latter has finally chosen to stick to Thermo Fisher's $1.3 billion takeover bid. With this ...

March 28 (Reuters) - Origin Technologies Corp, owned by Affymetrix Inc's former employees, withdrew its offer to buy the gene sequencing products maker, hours after Affymetrix said Origin's raised ...

Affymetrix Inc. on Wednesday postponed a vote on its proposed tie-up with Thermo Fisher Scientific Inc.,TMO-1.64%decrease; red down pointing triangle saying a new unsolicited bid from Origin ...

Newly-formed Origin Technologies is now offering $17/share in cash for Affymetrix (NASDAQ:AFFX), up from a prior $16.10/share. Origin has also upped the size of its reverse termination fee to $100M, ...

(Reuters) - Thermo Fisher Scientific Inc sent a letter to Affymetrix Inc shareholders on Tuesday, reiterating its argument that its $1.3 billion agreement to acquire the U.S. gene-testing company is ...

Affymetrix Inc. shares jumped 50% after Thermo Fisher Scientific Inc. said late Friday it agreed to acquire the biological test company for $14 a share cash, or $1.3 billion. Shares of Affymetrix, ...

Thermo Fisher Scientific Inc.TMO-0.58%decrease; red down pointing triangle will buy Affymetrix Inc. in a roughly $1.3 billion cash deal that would boost its biogenetic analysis portfolio, the company ...